Adaptive Biotechnologies Corporation (ADPT) is priced at $53.34 after the most recent trading session. At the very opening of the session, the stock price was $48.777 and reached a high price of $53.55, prior to closing the session it reached the value of $47.78. The stock touched a low price of $48.00.
Recently in News on December 6, 2020, Adaptive Biotechnologies Announces New Clinical Data Demonstrating Impact of clonoSEQ® Assay on Patients with Blood Cancers at the 62nd ASH Annual Meeting. MRD assessment with clonoSEQ improves outcomes both for patients and the healthcare system, as patients with undetectable MRD may be able to discontinue active treatment. You can read further details here
Even if you’re not actively in crypto, you deserve to know what’s actually going on...
Because while leading assets such as Bitcoin (BTC) and Ethereum (ETH) are climbing in value, a select group of public “crypto stocks” are surging right along with them. More importantly, these stocks are outpacing the returns these leading crypto assets aren already producing.
Click here to get the full story… along with our long list of backdoor Bitcoin strategies. It’s free. .
Adaptive Biotechnologies Corporation had a pretty favorable run when it comes to the market performance. The 1-year high price for the company’s stock is recorded $54.20 on 10/12/20, with the lowest value was $15.19 for the same time period, recorded on 03/16/20.
Adaptive Biotechnologies Corporation (ADPT) full year performance was 83.55%
Price records that include history of low and high prices in the period of 52 weeks can tell a lot about the stock’s existing status and the future performance. Presently, Adaptive Biotechnologies Corporation shares are logging -1.59% during the 52-week period from high price, and 251.15% higher than the lowest price point for the same timeframe. The stock’s price range for the 52-week period managed to maintain the performance between $15.19 and $54.20.
The company’s shares, operating in the sector of Healthcare managed to top a trading volume set approximately around 1404295 for the day, which was evidently higher, when compared to the average daily volumes of the shares.
When it comes to the year-to-date metrics, the Adaptive Biotechnologies Corporation (ADPT) recorded performance in the market was 78.28%, having the revenues showcasing 47.19% on a quarterly basis in comparison with the same period year before. At the time of this writing, the total market value of the company is set at 7.31B, as it employees total of 453 workers.
Specialists analysis on Adaptive Biotechnologies Corporation (ADPT)
During the last month, 6 analysts gave the Adaptive Biotechnologies Corporation a BUY rating, 0 of the polled analysts branded the stock as an OVERWEIGHT, 1 analysts were recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 of the polled analysts provided SELL rating.
According to the data provided on Barchart.com, the moving average of the company in the 100-day period was set at 44.90, with a change in the price was noted +13.49. In a similar fashion, Adaptive Biotechnologies Corporation posted a movement of +33.85% for the period of last 100 days, recording 857,365 in trading volumes.
Total Debt to Equity Ratio (D/E) can also provide valuable insight into the company’s financial health and market status. The debt to equity ratio can be calculated by dividing the present total liabilities of a company by shareholders’ equity. Debt to Equity thus makes a valuable metrics that describes the debt, company is using in order to support assets, correlating with the value of shareholders’ equity The total Debt to Equity ratio for ADPT is recording 0.00 at the time of this writing. In addition, long term Debt to Equity ratio is set at 0.00.
Trends and Technical analysis: Adaptive Biotechnologies Corporation (ADPT)
Raw Stochastic average of Adaptive Biotechnologies Corporation in the period of last 50 days is set at 91.31%. The result represents downgrade in oppose to Raw Stochastic average for the period of the last 20 days, recording 94.84%. In the last 20 days, the company’s Stochastic %K was 56.23% and its Stochastic %D was recorded 44.36%.
Now, considering the stocks previous presentation, multiple moving trends are noted. Year-to-date Price performance of the company’s stock appears to be pessimistic, given the fact the metric is recording 78.28%. Additionally, trading for the stock in the period of the last six months notably improved by 28.53%, alongside a boost of 83.55% for the period of the last 12 months. The shares increased approximately by 10.62% in the 7-day charts and went up by 4.67% in the period of the last 30 days. Common stock shares were driven by 47.19% during last recorded quarter.